PROACTIVE DOSE INTENSIFICATION BY PRECISION-GUIDED DOSING YIELDS ENHANCED DISEASE CONTROL IN INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Dubinsky, Marla C.
D'Haens, Geert
Vermeire, Severine
Laharie, David
Spencer, Elizabeth A.
Jain, Anjali
Dreesen, Erwin
Panetta, John C.
Rabizadeh, Shervin
Dervieux, Thierry
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1521
引用
收藏
页码:S801 / S802
页数:2
相关论文
共 50 条
  • [41] Infliximab Dosing for Patients With Inflammatory Bowel Disease, Based on Trough Levels
    Lowe, Anson W.
    Moseley, Richard H.
    GASTROENTEROLOGY, 2015, 148 (07) : 1261 - 1261
  • [42] Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease
    Khanna, Reena
    Vande Casteele, Niels
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (02) : 213 - 216
  • [43] The genetics of pediatric inflammatory bowel disease: Towards precision medicine
    Nazri, Ahmad Shahir Mohamad
    Yunus, Nazihah Mohd
    Musa, Marahaini
    BIOCELL, 2025, 49 (01) : 149 - 160
  • [44] Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
    Jagirdhar, Gowthami Sai Kogilathota
    Perez, Jose Andres
    Perez, Andrea Belen
    Surani, Salim
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (36) : 5211 - 5225
  • [45] Towards improved control of inflammatory bowel disease
    Eberhardson, Michael
    Hedin, Charlotte R. H.
    Carlson, Marie
    Tarnawski, Laura
    Levine, Yaakov A.
    Olofsson, Peder S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2019, 89 (03)
  • [46] Cumulative thiopurine dosing and keratinocyte skin cancer in inflammatory bowel disease: a case-control study
    Jansen, Fenna M.
    den Broeder, Nathan
    Lubeek, Satish F. K.
    Savelkoul, Edo H. J.
    Marcus, Carlijne M.
    Hoentjen, Frank
    van Dop, Willemijn A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (10) : 1123 - 1130
  • [47] Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies
    Wojciechowski, Jessica
    Upton, Richard N.
    Mould, Diane R.
    Wiese, Michael D.
    Foster, David J. R.
    AAPS JOURNAL, 2017, 19 (04): : 1136 - 1147
  • [48] Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies
    Jessica Wojciechowski
    Richard N. Upton
    Diane R. Mould
    Michael D. Wiese
    David J. R. Foster
    The AAPS Journal, 2017, 19 : 1136 - 1147
  • [49] Metabolomics for enhanced clinical understanding of inflammatory bowel disease
    Boye, Theresa Louise
    Hammerhoj, Alexander
    Nielsen, Ole Haagen
    Wang, Yulan
    LIFE SCIENCES, 2024, 359
  • [50] LOWER NEED FOR ADALIMUMAB DOSE INTENSIFICATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COMBINED IMMUNE SUPPRESSION COMPARED WITH ADALIMUMAB MONOTHERAPY
    Kovacs, Jan
    Kadleckova, Barbora
    Gombosova, Laura
    Novotna, Lucia
    Barlova, Erika
    Lucenicova, Jana
    Mikus, Peter
    Zakuciova, Maria
    Zelinkova, Zuzana
    GASTROENTEROLOGY, 2018, 154 (06) : S825 - S825